|
Date Submitted:
12/11/07
Hits: 23 Rating:  0/5 based on 0 votes
Clinical Trials Update: Dec. 19, 2006
Description:
This study will evaluate an investigational use of a medication called natalizumab to treat multiple sclerosis. Volunteers 18-55 who have not had prior treatment with natalizumab, any murine protein, or any other therapeutic monoclonal antibody may qualify.
Read the Complete Article Similar content: Clinical Trials Update: Dec. 18, 2006, in Prostate Cancer Clinical Trials Update: Dec. 29, 2006, in Leukemia Clinical Trials Update: Dec. 22, 2006, in Leukemia Clinical Trials Update: Aug. 20, 2007, in Prostate Cancer Clinical Trials Update: Oct. 31, 2007, in Multiple Sclerosis |
